Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Su

Showing results (1031-1040 of 1,103) with videos related to

Pageof 111
Sort By:
JAMA Dermatology|October 23, 2024
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 WeeksAmy S Paller, Pedro Mendes-Bastos, Elaine Siegfried, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Dedicator of cytokinesis 8-deficient CD4<sup>+</sup> T cells are biased to a T<sub>H</sub>2 effector fate at the expense of T<sub>H</sub>1 and T<sub>H</sub>17 cellsStuart G Tangye, Bethany Pillay, Katrina L Randall, et al.
The Journal of Experimental Medicine|November 26, 2014
DOCK8 regulates lymphocyte shape integrity for skin antiviral immunityQian Zhang, Christopher G Dove, Jyh Liang Hor, et al.
The Journal of Experimental Medicine|May 6, 2021
GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertensionKaela Drzewiecki, Jungmin Choi, Joseph Brancale, et al.
Medrxiv : the Preprint Server for Health Sciences|September 12, 2022
Deep immune profiling uncovers novel associations with clinical phenotypes of Multisystem Inflammatory Syndrome in Children (MIS-C)Christopher Redmond, Moses M Kitakule, Aran Son, et al.
JAMA Dermatology|April 12, 2023
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical TrialsAmy S Paller, Barry Ladizinski, Pedro Mendes-Bastos, et al.
Science (New York, N.Y.)|July 13, 2013
Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2DBenjamin Chaigne-Delalande, Feng-Yen Li, Geraldine M O'Connor, et al.
International Journal of Biological Sciences|October 20, 2022
Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2Limin Wang, Julián Candia, Lichun Ma, et al.
Toxins|August 28, 2019
Chronic Low Dose Oral Exposure to Microcystin-LR Exacerbates Hepatic Injury in a Murine Model of Non-Alcoholic Fatty Liver DiseaseApurva Lad, Robin C Su, Joshua D Breidenbach, et al.
ESMO Open|May 4, 2023
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancerG Galffy, I Lugowska, E V Poddubskaya, et al.
Pageof 111

Showing results (1031-1040 of 1,103) with videos related to

Sort By:
Pageof 111
JAMA Dermatology|October 23, 2024
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 WeeksAmy S Paller, Pedro Mendes-Bastos, Elaine Siegfried, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Dedicator of cytokinesis 8-deficient CD4<sup>+</sup> T cells are biased to a T<sub>H</sub>2 effector fate at the expense of T<sub>H</sub>1 and T<sub>H</sub>17 cellsStuart G Tangye, Bethany Pillay, Katrina L Randall, et al.
The Journal of Experimental Medicine|November 26, 2014
DOCK8 regulates lymphocyte shape integrity for skin antiviral immunityQian Zhang, Christopher G Dove, Jyh Liang Hor, et al.
The Journal of Experimental Medicine|May 6, 2021
GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertensionKaela Drzewiecki, Jungmin Choi, Joseph Brancale, et al.
Medrxiv : the Preprint Server for Health Sciences|September 12, 2022
Deep immune profiling uncovers novel associations with clinical phenotypes of Multisystem Inflammatory Syndrome in Children (MIS-C)Christopher Redmond, Moses M Kitakule, Aran Son, et al.
JAMA Dermatology|April 12, 2023
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical TrialsAmy S Paller, Barry Ladizinski, Pedro Mendes-Bastos, et al.
Science (New York, N.Y.)|July 13, 2013
Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2DBenjamin Chaigne-Delalande, Feng-Yen Li, Geraldine M O'Connor, et al.
International Journal of Biological Sciences|October 20, 2022
Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2Limin Wang, Julián Candia, Lichun Ma, et al.
Toxins|August 28, 2019
Chronic Low Dose Oral Exposure to Microcystin-LR Exacerbates Hepatic Injury in a Murine Model of Non-Alcoholic Fatty Liver DiseaseApurva Lad, Robin C Su, Joshua D Breidenbach, et al.
ESMO Open|May 4, 2023
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancerG Galffy, I Lugowska, E V Poddubskaya, et al.
Pageof 111